Analysis of FEV1 decline in relatively healthy heavy smokers: Implications of expressing changes in FEV1 in relative terms

Laura H. Thomsen; Asger Dirksen; Saher B. Shaker; Lene Theil Skovgaard; Magnus Dahlbäck; Jesper H. Pedersen

doi:10.3109/15412555.2013.830096

Analysis of FEV₁ decline in relatively healthy heavy smokers: Implications of expressing changes in FEV₁ in relative terms

Laura H. Thomsen^*, Asger Dirksen, Saher B. Shaker, Lene Theil Skovgaard, Magnus Dahlbäck, Jesper H. Pedersen

^*Corresponding author af dette arbejde

13 Citationer (Scopus)

Abstract

Progressive decline in lung function has been widely accepted as the hallmark of chronic obstructive pulmonary disease (COPD); however, recent evidence indicates that the rate of decline measured as decline in forced expiratory volume in one second (FEV₁) is higher in mild to moderate COPD than in severe COPD. Usually changes in FEV₁ are measured in ml that is "absolute"; however, changes can also be measured "relative" as a percentage of the actual FEV₁. We hypothesize that relative measurements could be more appropriate than absolute measurements for describing changes in lung function. We analyzed data from 3,218 relatively healthy heavy smokers who participated in the Danish Lung Cancer Screening Trial. The influences of age, sex, height, body mass index, smoking, and severity of airflow limitation on FEV₁ were analyzed in mixed effects models. In absolute terms those with the best lung function consistently showed the steepest decline, whereas in relative terms most fast decliners are found among those with low lung function. Measuring changes in relative terms implied statistically significant acceleration of decline with advancing age, smoking (pack-years) and severity of airflow limitation. Relative measurements may lead to a better understanding of changes in lung function. Smoking and severity of airflow limitation speed up the loss of lung function, and this emphasizes the importance of abstaining from smoking the sooner the better. Measuring changes in relative terms could have important implications for the interpretation of results from clinical trials where FEV₁ is the primary outcome. DLCST; www.ClinicalTrials.org, registration number: NCT00496977.

Originalsprog	Engelsk
Tidsskrift	C O P D
Vol/bind	11
Udgave nummer	1
Sider (fra-til)	96-104
Antal sider	9
ISSN	1541-2555
DOI	https://doi.org/10.3109/15412555.2013.830096
Status	Udgivet - feb. 2014

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.3109/15412555.2013.830096

https://www.tandfonline.com/doi/pdf/10.3109/15412555.2013.830096?needAccess=true&role=button

Citationsformater

@article{f533472f6ecf4731a50f303cc0233070,

title = "Analysis of FEV1 decline in relatively healthy heavy smokers: Implications of expressing changes in FEV1 in relative terms",

abstract = "Progressive decline in lung function has been widely accepted as the hallmark of chronic obstructive pulmonary disease (COPD); however, recent evidence indicates that the rate of decline measured as decline in forced expiratory volume in one second (FEV1) is higher in mild to moderate COPD than in severe COPD. Usually changes in FEV1 are measured in ml that is {"}absolute{"}; however, changes can also be measured {"}relative{"} as a percentage of the actual FEV1. We hypothesize that relative measurements could be more appropriate than absolute measurements for describing changes in lung function. We analyzed data from 3,218 relatively healthy heavy smokers who participated in the Danish Lung Cancer Screening Trial. The influences of age, sex, height, body mass index, smoking, and severity of airflow limitation on FEV1 were analyzed in mixed effects models. In absolute terms those with the best lung function consistently showed the steepest decline, whereas in relative terms most fast decliners are found among those with low lung function. Measuring changes in relative terms implied statistically significant acceleration of decline with advancing age, smoking (pack-years) and severity of airflow limitation. Relative measurements may lead to a better understanding of changes in lung function. Smoking and severity of airflow limitation speed up the loss of lung function, and this emphasizes the importance of abstaining from smoking the sooner the better. Measuring changes in relative terms could have important implications for the interpretation of results from clinical trials where FEV1 is the primary outcome. DLCST; www.ClinicalTrials.org, registration number: NCT00496977.",

keywords = "Epidemiology (pulmonary), Lung function tests, Relatively healthy heavy smokers, Smoking",

author = "Thomsen, {Laura H.} and Asger Dirksen and Shaker, {Saher B.} and Skovgaard, {Lene Theil} and Magnus Dahlb{\"a}ck and Pedersen, {Jesper H.}",

year = "2014",

month = feb,

doi = "10.3109/15412555.2013.830096",

language = "English",

volume = "11",

pages = "96--104",

journal = "COPD: Journal of Chronic Obstructive Pulmonary Disease",

issn = "1541-2555",

publisher = "Taylor & Francis",

number = "1",

}

TY - JOUR

T1 - Analysis of FEV1 decline in relatively healthy heavy smokers

T2 - Implications of expressing changes in FEV1 in relative terms

AU - Thomsen, Laura H.

AU - Dirksen, Asger

AU - Shaker, Saher B.

AU - Skovgaard, Lene Theil

AU - Dahlbäck, Magnus

AU - Pedersen, Jesper H.

PY - 2014/2

Y1 - 2014/2

N2 - Progressive decline in lung function has been widely accepted as the hallmark of chronic obstructive pulmonary disease (COPD); however, recent evidence indicates that the rate of decline measured as decline in forced expiratory volume in one second (FEV1) is higher in mild to moderate COPD than in severe COPD. Usually changes in FEV1 are measured in ml that is "absolute"; however, changes can also be measured "relative" as a percentage of the actual FEV1. We hypothesize that relative measurements could be more appropriate than absolute measurements for describing changes in lung function. We analyzed data from 3,218 relatively healthy heavy smokers who participated in the Danish Lung Cancer Screening Trial. The influences of age, sex, height, body mass index, smoking, and severity of airflow limitation on FEV1 were analyzed in mixed effects models. In absolute terms those with the best lung function consistently showed the steepest decline, whereas in relative terms most fast decliners are found among those with low lung function. Measuring changes in relative terms implied statistically significant acceleration of decline with advancing age, smoking (pack-years) and severity of airflow limitation. Relative measurements may lead to a better understanding of changes in lung function. Smoking and severity of airflow limitation speed up the loss of lung function, and this emphasizes the importance of abstaining from smoking the sooner the better. Measuring changes in relative terms could have important implications for the interpretation of results from clinical trials where FEV1 is the primary outcome. DLCST; www.ClinicalTrials.org, registration number: NCT00496977.

AB - Progressive decline in lung function has been widely accepted as the hallmark of chronic obstructive pulmonary disease (COPD); however, recent evidence indicates that the rate of decline measured as decline in forced expiratory volume in one second (FEV1) is higher in mild to moderate COPD than in severe COPD. Usually changes in FEV1 are measured in ml that is "absolute"; however, changes can also be measured "relative" as a percentage of the actual FEV1. We hypothesize that relative measurements could be more appropriate than absolute measurements for describing changes in lung function. We analyzed data from 3,218 relatively healthy heavy smokers who participated in the Danish Lung Cancer Screening Trial. The influences of age, sex, height, body mass index, smoking, and severity of airflow limitation on FEV1 were analyzed in mixed effects models. In absolute terms those with the best lung function consistently showed the steepest decline, whereas in relative terms most fast decliners are found among those with low lung function. Measuring changes in relative terms implied statistically significant acceleration of decline with advancing age, smoking (pack-years) and severity of airflow limitation. Relative measurements may lead to a better understanding of changes in lung function. Smoking and severity of airflow limitation speed up the loss of lung function, and this emphasizes the importance of abstaining from smoking the sooner the better. Measuring changes in relative terms could have important implications for the interpretation of results from clinical trials where FEV1 is the primary outcome. DLCST; www.ClinicalTrials.org, registration number: NCT00496977.

KW - Epidemiology (pulmonary)

KW - Lung function tests

KW - Relatively healthy heavy smokers

KW - Smoking

U2 - 10.3109/15412555.2013.830096

DO - 10.3109/15412555.2013.830096

M3 - Journal article

C2 - 24111638

AN - SCOPUS:84893219837

SN - 1541-2555

VL - 11

SP - 96

EP - 104

JO - COPD: Journal of Chronic Obstructive Pulmonary Disease

JF - COPD: Journal of Chronic Obstructive Pulmonary Disease

IS - 1

ER -